Tamoxifen-MRI Study

NCT00295100 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen

Sponsor

University of Pennsylvania

Collaborators

[object Object]
[object Object]